Introduction Obstructive sleep apnoea (OSA) is common in patients with chronic kidney disease (CKD) and may contribute to the progression of kidney disease either through direct effects of hypoxia on ...

My contrarian take on ResMed is that GLP-1 concerns are overstated, and even though a portion of market share will be lost, the remaining portion will be more beneficial to profitability. Other ...

DiveWire guarantees visibility for your news announcements through instant distribution to MedTech Dive’s audience and its 70,000 newsletter subscribers for 21 days.

Here are the supply chain updates ASC leaders need to know this week.